Page 258 - ACCCN's Critical Care Nursing
P. 258

Cardiovascular Alterations and Management 235


                                       Severe symptoms (NYHA Class IV)






                      Identify/treat acute   Non-pharmacological     Pharmacological
                         precipitant             treatment              treatment
                       Acute ischaemia/      Multidisciplinary care*
                          infarction          Salt/fl uid restriction
                         Arrhythmia          Exercise/conditioning
                       Non-compliance            program


                                                                         Diuretic
                                                                        + ACEI**





                                              No improvement                                   Improved


                                             Add spironolactone                             Add beta-blocker
                                                 +/- digoxin
                                           +/- angiotensin II receptor
                                                antagonists



                       No improvement                                   Improved


                     Add hydralazine/nitrate                         Add beta-blocker
                        Consider heart                              (irrespective of NYHA
                        transplantation                                 Class***)



                                               Not  tolerated                                  Tolerated



                                               Consider heart                               Continue medical
                                             transplantation if age                            treatment
                                             <65 years + no major
                                                comorbidity




                   *     Multidisciplinary care (pre-discharge and home review by a community care nurse, pharmacist and allied health personnel)
                      with education regarding prognosis, compliance, exercise and rehabilitation, lifestyle modifi cation, vaccinations and
                      self-monitoring.
                   **    If ACEI intolerant, use angiotensin II receptor antagonists instead.
                   ***   Patients with NYHA Class IV CHF should be challenged with beta-blockers provided they have been rendered euvolaemic
                      and do not have any contraindication to beta-blockers.
             FIGURE 10.13  Pharmacological treatment of refractory systolic heart failure. Courtesy National Heart Foundation of Australia and the Cardiac Society
                                 55
             of Australia and New Zealand.
   253   254   255   256   257   258   259   260   261   262   263